Pharma ETFs, Biotech ETFs: Benefiting from Swine and Politics
Drug distributors (pharmaceuticals) weathered the heart of the bear better than most areas. That’s not unusual for a defensive sub-segment of health care. Drug developers (biotech) have a history of volatility due to the hit-or-miss nature of creating the next big “thing’ or developing a ”flop.” Still, biotech has risk reduction qualities as a diversifier in one’s portfolio, as biotech [...] [...more]
